Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

77.45p
   
  • Change Today:
    -4.50p
  • 52 Week High: 85.55
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 965.23m
  • Volume: 3,148,382
  • Market Cap: £747.57m

Latest Deals

Traded Action Notifier PriceAmountValue
12-May-25 Transfer From Giles Wilson 0.000p 261 £0.00
12-May-25 Buy Giles Wilson 57.45p 261 £149.94
11-Apr-25 Transfer From Giles Wilson 0.000p 297 £0.00
11-Apr-25 Buy Giles Wilson 50.55p 297 £150.13
08-Apr-25 Buy Giles Wilson 46.92p 58 £27.21

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
24-Sep-24 Buy Robyn Perriss 51.55p 89,054 £45,907.34
24-Sep-24 Sell Robyn Perriss 51.50p 89,054 £45,862.81
24-Sep-24 Buy Andrew Harrison 51.53p 58,220 £29,999.54
27-Aug-24 Buy Lynne Weedall 74.41p 25,000 £18,603.62
25-Mar-25 Buy Giles Wilson 54.01p 32,640 £17,628.31

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £6,099,188
Giles Wilson 110,713 £85,747
Robyn Perriss 94,328 £73,057
Andrew Harrison 76,594 £59,322
Lynne Weedall 40,054 £31,022
Ian Rogers 20,270 £15,699
Ije Nwokori 5,405 £4,186

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £286,520,420
IngreGrsy Limited 369,942,440 £286,520,420
Permira Holdings Limited 364,142,440 £282,028,320
Artemis Investment Management LLP 86,997,521 £67,379,580
Fidelity Management & Research 32,500,000 £25,171,250
Intertrust Employee Benefit Trustee Limited 135,000 £104,558

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 77.45p
Change Today -4.50p
% Change -5.49 %
52 Week High 85.55
52 Week Low 47.52
Volume 3,148,382
Shares Issued 965.23m
Market Cap £747.57m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.19% below the market average28.19% below the market average28.19% below the market average28.19% below the market average28.19% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
6.48% below the market average6.48% below the market average6.48% below the market average6.48% below the market average6.48% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Income
43.29% below the market average43.29% below the market average43.29% below the market average43.29% below the market average43.29% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 09-Jun-2025

Time Volume / Share Price
16:38 718,261 @ 78.61p
14:55 127 @ 79.85p
16:35 816,094 @ 77.45p
16:35 1,783 @ 77.45p
16:35 1,359 @ 77.45p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page